Comment on: Effectiveness and safety of anti-tau drugs for Alzheimer's disease

J Am Geriatr Soc. 2023 Jul;71(7):2342-2344. doi: 10.1111/jgs.18351. Epub 2023 Apr 6.

Authors

Richard Stefanacci¹, Sonya Miller¹, Yin Sze Loh¹

Affiliation

¹ TauRx Pharmaceuticals Ltd., Aberdeen, UK.

PMID: 37021845
DOI: 10.1111/jgs.18351

No abstract available

Publication types

Letter
Comment

MeSH terms

Alzheimer Disease* / drug therapy
Amyloid beta-Peptides
Biomarkers
Humans
tau Proteins

Substances

tau Proteins
Amyloid beta-Peptides
Biomarkers